CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
- 4 Planned sale Chief Scientific Officer sold 106,160 shares at an average $17.41 ($1,847,942)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer, MRD sold 5,000 shares at $19.00 ($95,000)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Planned sale Chief People Officer sold 39,741 shares at $17.49 ($695,070)
- 4 Planned sale Chief Commercial Officer, MRD sold 11,000 shares at $18.00 ($198,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 3,115 shares at $13.04 ($40,620)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale President and COO sold 19,037 shares at $14.23 ($270,897)
- 4 Planned sale President and COO sold 57,180 shares at an average $13.96 ($798,423)
- ARS Other Annual Report to Security Holders
Page 4 of 42 · 836 filings